arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013 Heart Rhythm 2013;10(12):1932–1963 139 Berul CI, et al Results of a multicenter retrospective implantable cardioverterdefibrillator registry of pediatric and congenital heart disease patients J Am Coll Cardiol 2008;51(17):1685–1691 140 Garnreiter JM, et al Inappropriate ICD shocks in pediatrics and congenital heart disease patients: risk factors and programming strategies Heart Rhythm 2015;12(5):937–942 141 Napolitano C, Priori SG Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia Heart Rhythm 2007;4(5):675–678 142 Lahat H, et al A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel Am J Hum Genet 2001;69(6):1378–1384 143 Priori SG, Chen SR Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis Circ Res 2011;108(7):871– 883 144 Kannankeril PJ, et al Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia: a randomized clinical trial JAMA Cardiol 2017;2(7):759–766 145 Roston TM, et al Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry Circ Arrhythm Electrophysiol 2015;8(3):633–642 146 Di Diego JM, et al Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males Circulation 2002;106(15):2004–2011 147 Verheugt CL, et al The emerging burden of hospital admissions of adults with congenital heart disease Heart 2010;96(11):872–878 148 Labombarda F, et al Increasing prevalence of atrial fibrillation and permanent atrial arrhythmias in congenital heart disease J Am Coll Cardiol 2017;70(7):857–865 149 Khairy P, et al PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS) Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD) Can J Cardiol 2014;30(10):e1–e63 150 Hoyer AW, Balaji S The safety and efficacy of ibutilide in children and in patients with congenital heart disease Pacing Clin Electrophysiol 2007;30(8):1003–1008 151 Rao SO, et al Atrial tachycardias in young adults and adolescents with congenital heart disease: conversion using single dose oral sotalol Int J Cardiol 2009;136(3):253–257 152 Triedman JK, et al Radiofrequency ablation of intra-atrial reentrant tachycardia after surgical palliation of congenital heart disease Circulation 1995;91(3):707–714 153 Seslar SP, et al Ablation of nonautomatic focal atrial tachycardia in children and adults with congenital heart disease J Cardiovasc Electrophysiol 2006;17(4):359–365 154 Khairy P, et al Risk stratification in surgically repaired tetralogy of Fallot Expert Rev Cardiovasc Ther 2009;7(7):755–762 155 Khairy P Sudden cardiac death in transposition ... developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS) Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA),